Chronic myelogenous leukemia (CML) is characterized by the translocation of chromosomes 9 and 22, which generates the BCR-ABL fusion oncogene with constitutively active tyrosine kinase [1]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.